Chandler Allen, | |
13073 S Wheatfield Way, Draper, UT 84020-9253 | |
(801) 495-0946 | |
Not Available |
Full Name | Chandler Allen |
---|---|
Gender | Male |
Speciality | Counselor |
Location | 13073 S Wheatfield Way, Draper, Utah |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1013411107 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
101Y00000X | Counselor | (* (Not Available)) | Primary |
Mailing Address | Practice Location Address |
---|---|
Chandler Allen, 13073 S Wheatfield Way, Draper, UT 84020-9253 Ph: () - | Chandler Allen, 13073 S Wheatfield Way, Draper, UT 84020-9253 Ph: (801) 495-0946 |
News Archive
Responding to an urgent need for better antibacterial coatings on surgical sutures, scientists are reporting the discovery of a new coating that is almost 1,000 times more effective than the most widely used commercial coating.
A multicenter study led by scientists at the University of Pittsburgh School of Medicine shows that mild traumatic brain injury after blast exposure produces inflammation, oxidative stress and gene activation patterns akin to disorders of memory processing such as Alzheimer's disease.
Researchers in Japan and Canada have discovered a key component of the quality control mechanism that operates inside human cells - sometimes too well. The breakthrough has significant implications for the development of new treatments for cystic fibrosis (CF) and some other hereditary diseases, the researchers say. Their results were published July 25 in the journal Science.
AMPAC Fine Chemicals LLC (AFC), a subsidiary of American Pacific Corporation (Nasdaq: APFC) announced today that it received the Environmental Responsibility and Sustainability Award at the Annual Statewide Environmental Summit, sponsored by the California Manufacturers and Technology Association (CMTA), the Industrial Environmental Association (IEA) and the Chemical Industry Council of California (CICC) held in San Diego.
Today, the U.S. Food and Drug Administration granted accelerated approval to Jemperli (dostarlimab) for treating patients with recurrent or advanced endometrial cancer that has progressed on or following prior treatment with a platinum-containing chemotherapy and whose cancers have a specific genetic feature known as dMMR (which contain abnormalities that affect the proper repair of DNA inside the cell), as determined by an FDA-approved test.
› Verified 8 days ago
Mr. David Alexander Matheson, CMHC Counselor Medicare: Not Enrolled in Medicare Practice Location: 12067 S Draper Crest Ln Unit 11, Draper, UT 84020 Phone: 801-707-9265 | |
Cory Reich, Counselor Medicare: Not Enrolled in Medicare Practice Location: 11762 S State St, Ste 360, Draper, UT 84020 Phone: 801-438-3185 | |
Rebecca Perry, LMHC, LMFT Counselor Medicare: Not Enrolled in Medicare Practice Location: 795 E Sunrise View Dr, Draper, UT 84020 Phone: 954-546-1003 | |
Braeden M Guter, Counselor Medicare: Not Enrolled in Medicare Practice Location: 11650 S State St Ste 104, Draper, UT 84020 Phone: 801-867-3472 Fax: 801-401-7850 | |
Holly Joy Nelson, Counselor Medicare: Not Enrolled in Medicare Practice Location: 11894 S Landou Dr, Draper, UT 84020 Phone: 801-362-0326 | |
Warren Thomason, Counselor Medicare: Not Enrolled in Medicare Practice Location: 13073 S Wheatfield Way, Draper, UT 84020 Phone: 801-495-0946 |